DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2024年6月05日 (水) 午後 1:00 - 2024年6月06日 (木) 午後 5:30

(Central Europe Standard Time)

4051 Basel, Switzerland

TMF Management, Oversight and Inspection Experience

NEW OFFERING! This course teaches you oversight strategies for ensuring that you can sustain your inspection readiness throughout the clinical trial development process.

学部

Louise  Mawer

Louise Mawer

Director, Mirabilitas Ltd, United Kingdom

Louise Mawer, Director, Mirabilitas Ltd, is a GxP quality assurance auditor and trainer, with over twenty years’ experience in GCP, GLP and, more recently, GVP. A former UK Inspector for GCP and GLP, Louise spent seven years with the MHRA, before returning to the pharmaceutical industry in 2011 and establishing her own consultancy in 2013. Louise is Chair of the Quality Working Party of the European Forum for GCP (EFGCP) and a member of the Research Quality Association Research Practice Group. Louise has presented at national and international events, and developed training for GCP, GLP and GVP stakeholders and audit groups.

Marion  Mays

Marion Mays

CEO / Consultant, Jerion Consulting, United States

Marion Mays in an industry leader in Information Management with over 25 years of experience in the Pharmaceutical industry. An advocate for essential information management practices; competent training for all contributors and consumers of the documentation which supports the advancement of clinical outcomes. Highly skilled in developing and implementing enterprise-wide programs and systems in regulated environments with proven record of success in technical problem solving. In-depth experience with quality and compliance processes in the pharmaceutical industry including supporting organizations through major regulatory inspections with FDA, MHRA, EMA, and PMDA.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。